Dr. Gonzalez’s research focuses on the causes and treatment of metabolic diseases such as diabetes, obesity, and fatty liver disease, which lead to increased cancer risk. He also studies inflammatory bowel disease. From his group’s research on how chemicals in food, drugs and the environment (including chemical carcinogens) are metabolized, scientists now understand the molecular basis of why particular individuals are more prone to adverse drug reactions.